Janux Therapeutics Inc share price logo

Janux Therapeutics Inc Share Price

NASDAQ: JANX

Small Cap

$14.06

-0.10

(-0.67%)

as on

Janux Therapeutics Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $13.76
    $14.29
    downward going graph

    2.13%

    Downside

    1.64%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.12
    $35.34
    downward going graph

    13.80%

    Downside

    151.35%

    Upside

    downward going graph

Janux Therapeutics Inc share price movements today

Previous Close
$14.16
Open
$14.12
Volume
1.1M
Day's Low - High
$13.76 - $14.29
52 Week Low - High
$12.12 - $35.34

Janux Therapeutics Inc Historical Returns

1 Month Return
+ 7.49 %
3 Month Return
+ 1.96 %
1 Year Return
-53.04 %
3 Year Return
+ 21.94 %
5 Year Return
0 %

Janux Therapeutics Inc Stock Fundamentals & Key Indicators

Check Janux Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$861.4M

EPS (TTM)

-2.5861

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-52.87

Industry PE ratio

7.891681415929203

PEG Ratio

0

EBITDA

-155.6M

Revenue (TTM)

10.0M

Profit Margin

0.00%

Return On Equity TTM

-11.48%

Janux Therapeutics Inc Stock Valuation

Track how Janux Therapeutics Inc P/E has moved over time to understand its valuation trends.

Janux Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-51.60x)

June 30, 2024

Today (-52.87x)

March 21, 2026

Industry (7.89x)

March 21, 2026

Highest (-5.24x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -52.87x

Janux Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Janux Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Janux Therapeutics Inc image
Janux Therapeutics Inc
BUY$861.4MNA-52.870.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.3B116.54%133.528.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$116.3B110.08%29.9432.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA114.935.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B54.71%17.831.41%

Stock Returns calculator for Janux Therapeutics Inc Stock including INR - Dollar returns

The Janux Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Janux Therapeutics Inc investment value today

Current value as on today

₹56,405

Returns

₹43,595

(-43.59%)

Returns from Janux Therapeutics Inc Stock

₹53,039 (-53.04%)

Dollar Returns*

₹9,445 (+9.44%)

Analyst Recommendation on Janux Therapeutics Inc Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Janux Therapeutics Inc. Average target price of $54

Janux Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Janux Therapeutics Inc.

What analysts predicted

73.96%UPSIDE

Target Price

$54

Current Price

$14.06

Analyzed by

15 Analysts

Target

$54.00

Janux Therapeutics Inc target price $54, a slight upside of 73.96% compared to current price of $14.06. According to 15 analysts rating.

Janux Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Janux Therapeutics Inc Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Janux Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
1
8
0
-8
-
-
10
7
Gross Profit
2
1
0
8
0
-9
0
0
9
-1
Operating Income
-15
-16
-20
-13
-35
-29
-34
-45
-35
-42
EBITDA
-15
-15
-19
-13
-35
-28
-34
-44
-23
-31
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-11
-14
-5
-28
-20
-23
-33
-24
-31
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-11
-11
-14
-5
-28
-20
-23
-33
-24
-31
Net Profit Margin
-459.59%
-477.77%
-1178.91%
-66.98%
-6391.57%
237.50%
0.00%
0.00%
-243.13%
-405.41%

Janux Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
3
8
8
10
10
Gross Profit
0
0
3
8
6
8
7
Operating Income
-3
-4
-32
-67
-72
-98
-157
EBITDA
-3
-6
-32
-66
-71
-96
-111
Interest Expense
0
0
0
4
-
-
-
Depreciation
0
0
0
0
1
2
2
Income Before Tax
-4
-6
-32
-63
-58
-68
-113
Income Tax Expense
0
-1
0
-8
1
-
-
Net Income
-4
-6
-32
-54
-58
-68
-113
Net Profit Margin
0.00%
-1785.26%
-895.22%
-628.82%
-721.18%
-651.62%
-1136.25%

Janux Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-11
-14
-5
-28
-20
-23
-33
-24
81
Operating Cash Flow
-9
-14
-10
-2
-16
-17
-23
-12
-28
Investing Cash Flow
11
-113
-190
12
33
-340
1
8
29
Financing Cash Flow
0
322
2
1
386
0
0
0
2
Change in Cash
2
193
-198
12
403
-356
-21
-4
3

Janux Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-32
-63
-58
-68
-113
Operating Cash Flow
-4
-16
-42
-50
-43
-82
Investing Cash Flow
-340
-340
58
-41
-258
-300
Financing Cash Flow
11
386
0
59
713
4
Change in Cash
7
28
15
-32
411
-378

Global Institutional Holdings in Janux Therapeutics Inc

Funds
Holdings
RA Capital Management, LLC
18.39%
Orbimed Advisors, LLC
2.9%
HHG PLC
7.73%
BlackRock Inc
6.13%
State Street Corp
3.11%
See all

Janux Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 02 December

    Tue, 10:03 PM

    -

    Janux Therapeutics stock fell 47% after disappointing early-stage prostate cancer trial data.

Insights on Janux Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, JANX stock has moved up by 3.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, JANX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 64.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 10.0M → 7.88M (in $), with an average decrease of 21.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -24.31M → -31.94M (in $), with an average decrease of 31.4% per quarter

About Janux Therapeutics Inc

janux therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary tumor activated t cell engager (tractr) platform technology to better treat patients suffering from cancer. janux’s initial focus is on developing a novel class of t cell engagers (tces), and its lead product candidates are designed to target clinically validated drug targets. while tce therapeutics have displayed potent anti-tumor activity in hematological cancers, developing tces to treat solid tumors have faced challenges due to the limitations of prior tce technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. janux is using its tractr platform technology to engineer product candidates designed to overcome these limitations. janux is developing a broad pipeline with lead programs targeting prostate-specific membr
OrganisationJanux Therapeutics Inc
Headquarters10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130
IndustryServices
CEODr. David Alan Campbell Ph.D.
E-voting on sharesClick here to vote

Key Management of Janux Therapeutics Inc

Name

Title

Mr. Charles M. Winter

Chief Technical Officer

Mr. James Pennington

General Counsel & Corporate Secretary

Ms. Janeen Doyle

Chief Corporate & Business Development Officer

Dr. William Y. Go M.D., Ph.D.

Chief Medical Officer

Dr. David Alan Campbell Ph.D.

President, CEO & Director

Dr. Thomas Diraimondo Ph.D.

Chief Scientific Officer

Mr. Matt Whitmire

Vice President of Finance

Ms. Maria Dobek

Vice President of Accounting

FAQs

What is Janux Therapeutics Inc share price today?

Janux Therapeutics Inc share price today is $14.06 as on at the close of the market. Janux Therapeutics Inc share today touched a day high of $14.29 and a low of $13.76.

What is the 52 week high and 52 week low for Janux Therapeutics Inc share?

Janux Therapeutics Inc share touched a 52 week high of $35.34 on and a 52 week low of $12.12 on . Janux Therapeutics Inc stock price today i.e. is closed at $14.06,which is 60.22% down from its 52 week high and 16.01% up from its 52 week low.

What is Janux Therapeutics Inc's market capitalisation today?

Janux Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Janux Therapeutics Inc Stock (JANX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Janux Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Janux Therapeutics Inc Shares that will get you 0.1067 shares as per Janux Therapeutics Inc share price of $14.06 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Janux Therapeutics Inc Stock (JANX) from India?

Indian investors can start investing in Janux Therapeutics Inc (JANX) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Janux Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Janux Therapeutics Inc share’s latest price of $14.06 as on March 21, 2026 at 1:29 am IST, you will get 0.7112 shares of Janux Therapeutics Inc. Learn more about fractional shares .